CSSPX | VGSCX | CSSPX / VGSCX | |
Total Expense Ratio | 0.90 | 1.99 | 45% |
Annual Report Gross Expense Ratio | 0.93 | 2.16 | 43% |
Fund Existence | 28 years | 17 years | - |
Gain YTD | 11.304 | 9.890 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 2500 | 4,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.08B | 391M | 532% |
Annual Yield % from dividends | 2.74 | 1.33 | 206% |
Returns for 1 year | 1.03 | 1.11 | 93% |
Returns for 3 years | 33.08 | 31.57 | 105% |
Returns for 5 years | 30.20 | 28.18 | 107% |
Returns for 10 years | 48.24 | 44.44 | 109% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 75.17 | 0.46 | +0.62% |
Janus Henderson Global Life Sciences T | |||
SSRRX | 6.71 | 0.03 | +0.45% |
Touchstone Small Company R6 | |||
GMVRX | 16.40 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity R | |||
ABALX | 39.02 | 0.05 | +0.13% |
American Funds American Balanced A | |||
SGQIX | 46.28 | -0.03 | -0.06% |
DWS International Growth Inst |